| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 104.29B | 82.52B | 59.28B | 50.31B | 33.93B |
| Gross Profit | 21.34B | 13.62B | 9.84B | 7.09B | 3.58B |
| EBITDA | 18.27B | 12.73B | 9.13B | 6.29B | 2.52B |
| Net Income | 4.74B | 2.95B | 2.33B | 1.25B | ― |
Balance Sheet | |||||
| Total Assets | 170.37B | 160.66B | 134.60B | 90.72B | 78.31B |
| Cash, Cash Equivalents and Short-Term Investments | 20.08B | 14.83B | 14.13B | 12.59B | 7.69B |
| Total Debt | 54.53B | 57.00B | 50.19B | 20.95B | 12.87B |
| Total Liabilities | 105.99B | 102.09B | 81.34B | 54.03B | 46.52B |
| Stockholders Equity | 44.90B | 37.80B | 33.08B | 32.88B | 29.22B |
Cash Flow | |||||
| Free Cash Flow | 8.56B | -6.76B | -2.33B | -1.24B | -1.73B |
| Operating Cash Flow | 21.49B | 13.34B | 6.85B | 2.97B | 1.82B |
| Investing Cash Flow | -13.61B | -22.80B | -20.62B | -5.25B | -2.61B |
| Financing Cash Flow | -1.87B | 11.00B | 14.44B | 5.46B | 2.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$82.75B | 17.50 | 27.52% | 0.54% | 48.74% | 56.71% | |
70 Outperform | HK$102.80B | 27.53 | 11.01% | 0.16% | 56.67% | 139.25% | |
65 Neutral | HK$1.01T | 10.07 | 30.60% | 1.55% | 22.04% | 75.35% | |
64 Neutral | HK$30.21B | 6.03 | 33.81% | 1.40% | 10.57% | 112.84% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | HK$100.74B | 20.10 | 51.43% | 2.51% | 221.33% | 221.57% | |
55 Neutral | HK$177.87B | 33.06 | ― | 0.93% | ― | ― |